Abstract To examine the relationship between folic acid preconception counseling (PCC) and folic acid use and reasons for non-use among women with a recent live birth. We analyzed Maryland Pregnancy Risk Assessment Monitoring System (PRAMS) survey responses from 2009 to 2011 (n = 4,426, response rate = 67 %). Multivariable weighted logistic regression models were used to explore associations between folic acid PCC receipt and folic acid use and reasons for non-use. Approximately 30 % of women reported daily folic acid use the month before pregnancy, with lower rates among those who were \30, non-white, or unmarried; received WIC during pregnancy; had suffered a stressful event prepregnancy; smoked prepregnancy; had a previous live birth; or had an unintended pregnancy (all p \ 0.05). The most common reasons for folic acid non-use were ''not planning pregnancy'' (61 %) and ''didn't think needed to take'' (41 %). Folic acid PCC receipt was reported by 27 % of women and was associated with three times the odds of folic acid use (adjusted odds ratio [aOR] 3.15, 95 % CI 2.47-4.03) and half the odds of reporting ''didn't think needed to take'' (aOR 0.47, 95 % CI 0.28-0.78) as a reason for non-use. Less than one-third of recent Maryland mothers reported using folic acid daily before pregnancy and only 27 % reported receiving folic acid PCC. However, folic acid PCC was associated with increased folic acid use and decreased reporting that women did not think they needed to take folic acid. Our data support initiatives to promote provision of folic acid PCC to all women of childbearing age.
Introduction
Neural tube defects (NTDs) remain common, affecting over 2,500 infants born annually in the United States [1] . They are the second most common cause of serious birth defects and are costly, associated with more than $85 million in hospital costs per year [2] . There is strong evidence that taking folic acid prior to conception and during the first trimester of pregnancy can reduce the risk of NTDs by up to 70 % [3] . Recommendations from the centers for disease control and prevention (CDC) [4] , United States Preventive Services Task Force (USPSTF) [5] and others [6] [7] [8] therefore encourage daily folic acid supplementation (0.4 mg) for all women of childbearing age. Although rates of NTDs have fallen since these clinical guidelines were established [9] and following grain fortification [10] , the rate of NTDs remains 60 % above the Healthy People 2010 goal rate [11] and continues to be a priority for the Healthy People 2020 goals [12] .
Despite recommendations, the majority of women of do not take folic acid daily before pregnancy. The most recent national estimates suggest that only 30 % of women with a recent pregnancy used folic acid daily before they became pregnant [11, 13, 14] . However, prior studies of the reasons women do not take folic acid have been limited, either in size [15, 16] or because they have not focused on use by women before pregnancy [17] , when folic acid use is most important to prevent NTDs.
One potentially effective strategy to increase folic acid use and address reasons for not taking folic acid is preconception counseling (PCC) [18] [19] [20] [21] [22] [23] . PCC has shown promise in promoting healthy prepregnancy behaviors and affecting birth outcomes in mothers with chronic disease [24, 25] . However, though PCC is recommended for all women of childbearing age [26] , studies estimate that only 30 % of women receive PCC during the 12 months before pregnancy [27] .
Few large-scale studies have explored the association between PCC receipt and folic acid use [25, 28] . Previous studies have reported the effect of PCC in general [20, 25, 28] rather than the effect of folic acid PCC, i.e. PCC which specifically addresses folic acid supplementation, which is most relevant to efforts to increase folic acid use. The objective of this study is to examine the relationship between folic acid PCC and prepregnancy daily folic acid use, as well as to describe the reasons women do not take folic acid prepregnancy, using data from a population-based survey.
Methods

Study Design
We analyzed 2009-2011 data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS), a population-based survey of postpartum women 2-9 months after delivery, designed to assess selected maternal behaviors and experiences that occur before, during, and shortly after pregnancy. PRAMS is an ongoing survey conducted by the Maryland Department of Health and Mental Hygiene (DHMH) with the support of the CDC. A random sample of approximately 200 new mothers, stratified by maternal age and infant birth weight, is drawn every month from eligible birth certificates. Women are first contacted by mail and, if there is no response to three mailed surveys, telephone interviews are attempted. The weighted aggregate response rate for the 2009-2011 surveys was 67.0 %. Details regarding the PRAMS design and methods have been previously published [29] and are also available at http://www.cdc.gov/prams/Methodology. htm [30] . Maryland PRAMS 2009-2011 is unique in that it is the only available large dataset from those years describing both receipt of folic acid PCC and reasons for not taking folic acid. One other state, Ohio, has PRAMS data on these topics available but only from 2009 to 2010. Ohio data were not included in our analysis.
Measures
Dependent Variables
The primary dependent variable, prepregnancy daily folic acid use, was assessed by response to the question: ''During the month before you got pregnant with your new baby, how many times a week did you take a multivitamin, a prenatal vitamin, or a folic acid vitamin?'' Responses were dichotomized to indicate daily versus not daily intake. Additionally a secondary outcome, reasons for not taking folic acid, was examined. Women who reported not taking folic acid at all in the month before pregnancy were asked: ''What were your reasons for not taking multivitamins, prenatal vitamins, or folic acid vitamins during the month before you got pregnant with your new baby?'' Response categories included: (1) ''I wasn't planning to get pregnant,'' (2) ''I didn't think I needed to take vitamins,'' (3) ''The vitamins were too expensive,'' (4) ''The vitamins gave me side effects (such as constipation)'' and (5) ''Other.'' Women who indicated not taking folic acid but did not choose any of the five reasons were classified as reporting ''unknown reason.'' Respondents could check all reasons that applied and thus each reason was coded as a distinct dichotomous variable indicating ''yes'' or ''no''.
Independent Variables
The primary independent variable of interest was receipt of folic acid PCC. This was assessed by response to the question, ''Before you got pregnant with your new baby, did a doctor, nurse, or other health care worker talk with you about how to prepare for a healthy pregnancy and baby?'' Women with a ''yes'' response were prompted to respond to a follow-up question, ''Before you got pregnant with your new baby, did a doctor, nurse, or other health care worker talk with you about any of the things listed below? Please count only discussions, not reading materials or videos.'' Women could respond ''yes'' or ''no'' for 11 content areas of PCC, including ''taking vitamins with folic acid before pregnancy.'' Women were considered to have received PCC in general if they answered ''yes'' to the first question and to have received folic acid PCC if they answered ''yes'' to the first question and ''yes'' for counseling about ''taking vitamins with folic acid'' for the follow-up question.
Covariates
We considered covariates using an adaptation of the framework of predisposing, enabling and need factors proposed by Aday and Andersen [31, 32] . For predisposing factors, we included age (\30 or C30 years), race/ethnicity (White Non-Hispanic, Black Non-Hispanic, Asian NonHispanic, Hispanic, or Other), education (B12 grades or [12 grades), marital status (married or other) and WIC receipt (yes or no; during pregnancy). The only enabling factor included was health insurance (Medicaid, other or none; month before pregnancy). We included as need factors stressful events prepregnancy (yes or no; 12 months before pregnancy), chronic conditions (yes or no; 3 months before pregnancy), smoking prepregnancy (yes or no; 3 months before pregnancy), previous live birth (yes or no) and pregnancy intention (intended or unintended). Intended pregnancy was defined as women responding that they wanted to be pregnant ''sooner'' or ''then,'' while unintended pregnancy meant they responded that they wanted to be pregnant ''later'' or ''didn't want to be pregnant then or later.'' Chronic conditions before pregnancy was defined as answering ''yes'' to the question, ''Before you got pregnant with your new baby, were you ever told by a doctor, nurse, or other health care worker that you had Type 1 or Type 2 diabetes?'' or answering ''yes'' to, ''During the 3 months before you got pregnant with your new baby, did you have any of the following health problems?… Asthma, high blood pressure (hypertension), anemia (poor blood, low iron), heart problems, epilepsy (seizures), thyroid problems, depression, anxiety.'' Income level was not included because of a high degree of missingness ([5 %). Additional covariates that were considered included maternal body mass index, previous low birth weight infant, previous preterm infant and maternal alcohol use prepregnancy, but these were excluded due to lack of significance in bivariate models.
Data Analysis
Our sample included women with data available with regard to both prepregnancy daily folic acid use and receipt of folic acid PCC, which excluded 122 women (2.7 %) from analysis. We calculated the percentages of women reporting prepregnancy daily folic acid use and each of the reasons for not taking folic acid. F-statistics were used to examine differences in proportions by selected maternal characteristics. Next, associations between maternal characteristics and prepregnancy daily folic acid use were explored using logistic regression to compute unadjusted prevalence odds ratios (ORs) and 95 % confidence intervals.
Multivariable logistic regression was then used to assess associations between receipt of folic acid PCC and prepregnancy daily folic acid use and reasons for not taking folic acid, adjusting for the covariates discussed above. Missingness of all covariates included was \3 % in each model. Multi-collinearity was examined and was not a factor in any of the models.
All analyses were performed on weighted data, accounting for the complex survey design, non-response and non-coverage, using STATA 13 SE software (StataCorp LP, College Station, TX, USA). The study was approved by the Institutional Review Boards of the Maryland Department of Health and Mental Hygiene and Johns Hopkins School of Medicine.
Results
Of the 4,426 women in our sample, 31.5 % took folic acid daily during the month before their most recent pregnancy and 26.7 % reported receiving folic acid PCC. PCC in general, i.e. on any topic, was reported by 32.0 % of respondents. Receipt of folic acid PCC differed significantly for all maternal characteristics, except chronic conditions. The majority of women in the full sample were \30 years old (55.2 %), White Non-Hispanic (46.5 %), educated more than 12 grades (64.0 %), and married (59.0 %). Approximately 43.7 % received WIC during pregnancy, 14.4 % were on Medicaid, and a majority reported one or more stressful events prepregnancy (71.7 %). Most reported no chronic condition the 3 months before pregnancy (63.0 %), not smoking during the 3 months before pregnancy (77.8 %), and a previous live birth (57.3 %). About half of respondents reported that their most recent pregnancies were intended (54.7 %) ( Table 1) .
In bivariate models, folic acid PCC was associated with four and a half times the odds of preconception daily folic acid use (adjusted odds ratio [aOR] 4.54; 95 % CI 3.66-5.62), as noted in Table 2 . In multivariable analysis, receipt of folic acid PCC remained significant and was associated with three times the odds of daily folic acid use (aOR 3.17; 95 % CI 2.48-4.06). Age 30 years or older (aOR 1.65; 95 % CI 1.29-2.12) and having an intended pregnancy (aOR 1.83; 95 % CI 1.41-2.38) also remained significantly associated with increased odds of daily folic acid use. Asian Non-Hispanic race/ethnicity, receiving WIC during pregnancy, having a stressful event prepregnancy, smoking prepregnancy, and having a previous live birth remained significantly associated with lower odds of daily folic acid use (Table 3) .
We additionally examined the outcome of folic acid use four or more days per week and found very similar outcomes. In multivariable analysis, folic acid PCC was associated with increased odds of folic acid use four or more days per week at a greater magnitude than for daily folic acid use (aOR 4.56, 95 % CI 3.54-5.88). The significance and direction of associations of all covariates was the same, except for previous live birth which became not significant Matern Child Health J (2015) 19:1974-1984 1977 (p = 0.051). Moreover, in our multivariable models of daily folic acid use and each reason for folic acid non-use, we included an interaction term to explore the potential of effect modification by pregnancy intention; however, there was no evidence of an interaction.
The most common reason reported for not taking folic acid was, ''I wasn't planning to get pregnant'' (60.9 %), followed by, ''I didn't think I needed to take vitamins'' (40.9 %). ''Other'' reasons were written in by 11.6 % of women. There were significant differences in reasons reported by all maternal characteristics (Table 4) .
Folic acid PCC was also associated with half the odds of reporting ''didn't think needed'' (aOR 0.47; 95 % CI 0.28-0.78) and two times the odds of reporting ''other'' reasons (aOR 2.04, 95 % 1.17-3.53). Reason 1, ''not planning pregnancy,'' had lower odds of being reported by women who were of Non-Hispanic Black race/ethnicity or had an intended pregnancy and increased odds of being reported by women who were not married. Reason 2, ''didn't think needed to take,'' had lower odds of being reported by women age 30 or more and increased odds of being reported by women who were non-White, received WIC during pregnancy, or had an intended pregnancy. Reason 3, that folic acid vitamins were ''too expensive,'' had lower odds of being endorsed by Non-Hispanic Black women and increased odds among women who were unmarried, were uninsured, had chronic conditions or had a previous live birth. Reason 4, ''side effects,'' had lower odds of being endorsed by Asian women than White women. Reason 5, ''other'' had twice the odds of being reported by women with an intended pregnancy. ''Unknown reason'' had almost three times the odds of being reported by unmarried women (Table 5) .
Discussion
Based upon data from a population-based survey of over 4,400 women with recent live births, we found that less than one-third (31.5 %) of recent mothers in Maryland reported daily folic acid use in the month before their most recent pregnancy, consistent with national estimates [11] . Only about one-quarter of women (26.7 %) reported receipt of folic acid PCC before pregnancy, consistent with other studies showing similar rates of general PCC in other states and nationally [11, 13, 14, 25, 27] . A number of predisposing and need factors were associated with folic acid use, with lower use among women who were younger [11, 27, 28, 33] , non-White [11, 27, 28] , had a previous live birth [28] , or had an unintended pregnancy [27, 28, 33, 34] , also consistent with previous studies. However, our results showing lower use among women who received WIC, suffered stressful events prepregnancy or smoked prepregnancy were unique. Our study also examined reasons for not taking folic acid, finding the most common reasons were that women were ''not planning pregnancy'' and ''didn't think needed to take.'' Finally, our study uniquely assessed the association between folic acid PCC and folic acid use and found folic acid PCC was associated with increased odds of self-reported folic acid use and decreased odds of endorsing ''didn't think needed'' as a reason for not taking folic acid. Despite long-standing efforts to encourage folic acid use [17] , the majority of women in our sample did not report using folic acid daily before pregnancy, with lower rates among women who received WIC during pregnancy, suffered stressful events prepregnancy or smoked prepregnancy. Lower odds of folic acid intake among women receiving WIC and smoking prior to pregnancy were previously reported by Rosenberg et al. [30] , however these were unadjusted analyses. Given receipt of WIC is a predisposing factor as a proxy for socioeconomic status, it was not surprising that it was associated with decreased folic acid use. It was also not surprising that a risky health behavior like smoking and stressful life events would be associated with less of a protective health behavior like folic acid use. The finding that women who smoke were less likely to have used folic acid prepregnancy is of concern because chronic smoking has been associated with lower folic acid blood levels and so these women may be at increased risk for delivering infants with NTDs [32] . The association between stressful events and lower folic acid use reinforces the importance of patients' social situation in their decision and ability to take folic acid.
To our knowledge, our study is the first populationbased study to examine the association between folic acid PCC and prepregnancy daily folic acid use. Our study adds to the growing body of evidence suggesting that PCC may be an effective means of increasing folic acid use, as well as addressing other maternal risk factors [23, 25, 27 ]. Yet, only one-quarter of recent Maryland mothers reported having received folic acid PCC in the year before their most recent pregnancy. Multiple barriers to PCC conversations, such as feasibility, time constraints and reimbursement, have been noted [21] . Still, data have shown that doctor recommendation is the single greatest reason women would start taking a multivitamin with folic acid [17] . Moreover, there is evidence that brief, 30-60 second counseling on folic acid by clinicians directed at all women of childbearing age, not just those considering pregnancy, is effective in increasing folic acid use [22] . The lack of folic acid PCC provision is a large missed opportunity for the maternal and child health community. The potential exists to address folic acid use at all locations of contact between health professionals and women of childbearing age [18, 19, 35, 36] , including adult, pediatric and obstetrician/gynecologist practices, as well as schools and pharmacies.
Our study is also, to our knowledge, the first large study to examine the reasons women have for not taking folic Reasons for non-use not mutually exclusive. Possible n = 2,093 for those reporting no folic acid use; small amount of missing for each reason n = 2,076-93. Small amount (\3.0 %) of missing data for all characteristics (except PCC and age 0 %).
Other race/ethnicity (n = 10) omitted from table. a, b, c, d, e and f signify p \ 0.05 for reasons 1, 2, 3, 4, 5 and 6, respectively. P-values from F statistic Matern Child Health J (2015) 19:1974-1984 1981 acid before pregnancy and the association between PCC and these reasons. Importantly, given the second most frequent reason for not taking folic acid was ''didn't think needed to take,'' and receiving folic acid PCC was associated with lower odds of reporting this reason, our findings suggest again that folic acid PCC is of critical importance. However, that this counseling was associated with increases in women reporting ''other'' reasons also suggests that there are additional barriers beyond knowledge gaps, e.g. ''forgetting,'' ''being too busy'', ''feeling lazy,'' or other logistical barriers that must be addressed in order to promote folic acid use [17] . Our findings regarding factors associated with daily folic acid intake and reasons for not taking folic acid are helpful in identifying at-risk populations for whom targeted public health initiatives are needed and can provide important clues to inform the design of such interventions. For example, our data suggest younger women are less likely to take folic acid and more likely to believe they ''don't need to take'' folic acid. Others studies have found that women less than 25 years old are less receptive to folic acid recommendations compared to older women [37] . Therefore messaging of the importance of folic acid is needed, not only during medical visits and but in other locations (e.g. in schools and pharmacies) and in public health campaigns, in order to reach women at a younger age. To be successful, this messaging may require emphasis on healthy lifestyle choices in addition to focus on birth defect prevention [37] .
Another important risk factor for folic acid non-use was unintended pregnancy. The most common reason for not taking folic acid before pregnancy in our population was ''not planning pregnancy,'' and 45 % of women in our sample, and roughly 50 % of women nationwide, have unintended pregnancies [38, 39] . These findings underscore the necessity of providing folic acid PCC not just in scheduled visits for those planning pregnancy [21] , but to all women of childbearing age [5, 7, 26] , whether they are planning pregnancy or not, and communicating during visits and via public health messaging that these women should all be taking folic acid daily as part of their health routine [21, 25, 26, 33, 36] .
Though some investigators have questioned the benefits of folic acid supplementation in preventing NTDs since grain fortification [40, 41] , at this time the preponderance of the evidence and current professional guidelines still support folic acid supplementation for all women of childbearing age, particularly given the very low risk of adverse effects [5, 7, 26] .
There are several limitations to this study. This study includes data from a single state for a three-year period, potentially limiting generalizability. PRAMS data are retrospective and self-reported and therefore subject to recall bias. In particular, the relationship between our primary independent variable and primary outcome, folic acid PCC and folic acid use, may be inflated by recall bias. As is a challenge with all population-based surveys, the response rate for these years was low, though still meeting the required threshold set by the CDC for analysis, and this may impact the generalizability of our findings. The question used to assess folic acid use refers to ''daily use of a multivitamin, prenatal vitamin, or a folic acid supplement,'' which may overestimate our primary outcome, though most adult multivitamins currently contain at least the 400 mcg per day recommended for women of childbearing age [42] . Finally, PRAMS does not include potentially important information, such as incidence of NTDs in previous pregnancies or in the index child or maternal All listed characteristics included in each model. Small amount (\3.0 %) of missing data for all characteristics (except PCC and age 0 %).
aOR for other race/ethnicity (n = 10) omitted from table. * p \ 0.05, ** p \ 0.01, *** p \ 0.001 diet during pregnancy, which may be relevant to our results. Despite these limitations, the data source used allowed a unique opportunity to use population-based data to assess receipt of folic acid PCC, folic acid use, and reasons for folic acid non-use, among women with a recent live birth.
In conclusion, the majority of Maryland mothers with a recent live birth did not report daily folic acid use prior to their most recent pregnancy. Targeting efforts to increase folic acid use among high risk groups, such as those of low socioeconomic status, smokers or those suffering stressful events, may be effective. However, universal outreach is essential, especially public health messaging to emphasize the need for women to take folic acid daily when they reach childbearing age, whether or not they are planning pregnancy. Folic acid PCC may serve as an effective strategy to increase folic acid use, but prevalence of such PCC receipt is low nationally and in our sample. Efforts are needed to overcome barriers and provide folic acid PCC to every woman of childbearing age at every opportunity, in order to improve birth outcomes.
